Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag with Decitabine or Azacitidine in Elderly AML
NCT02446145Phase 2Terminated
- Sponsor
- Technische Universität Dresden
- Start
- May 2015
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eltrombopag in acute myeloid leukemia (AML), sponsored by Technische Universität Dresden. Started May 2015; status: terminated.
02
Drugs
eltrombopag
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02446145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02446145.